Center for Liver Diseases and Liver Masses
The Center for Liver Diseases and Liver Masses at Robert Wood Johnson University Hospital (RWJUH), in collaboration with Rutgers Robert Wood Johnson Medical School, offers patients expertise in the diagnosis and management of complex liver disease using the latest and most effective medical and surgical therapies to improve quality of life.
Highly-specialized expertise combined with the resources and services of New Jersey’s leading academic medical center, enables patients to access one, comprehensive and centralized program for the care of all liver-related diseases and masses.
Multi-Specialty, Team Approach to Coordinated Care
The full team of clinicians and researchers, with unparalleled expertise in liver-related diseases offers leading medical and surgical therapies, as well as the most advanced research and clinical trials to ensure the best possible options and outcomes for each patient.
The team approach assures patients that care is coordinated across the wide range of specialties involved in the treatment plan, including:
- Hepatology
- Surgery
- Medical and radiation oncology
- Radiology
- Psychiatry
- Nutrition
- Pediatrics
- Interventional radiology
- Bariatric surgery
- Pathology
- Hepatobiliary surgery
Liver Conditions Treated
The Center for Liver Diseases and Liver Masses treats a wide range of liver conditions, including, but not limited to:
- Acute liver failure
- Alpha-1 antitryspin deficiency
- Autoimmune hepatitis
- Bile duct cancer (cholangiocarcinoma)
- Cirrhosis
- Familial amyloidosis
- Hemochromatosis
- Hepatic (liver) resection
- Hepatitis
- Advanced hepatobiliary malignancy
- Nonalcoholic fatty liver disease
- Portal hypertension
- Pre and post-op liver transplant patients
- Primary biliary cirrhosis
- Primary sclerosis cholangitis
- Wilson’s disease
Evaluation and Appointments
At the Center for Liver Diseases and Liver Masses, patients benefit from a team-based approach, with the initial evaluation handled by a hepatologist, a specially-trained gastroenterologist, and may include fibroscan.
Fibroscan is a new, non-invasive technology for assessing liver fibrosis (scarring) and fatty content, which helps reduce the need for invasive tests like liver biopsy. It is a painless test which can be done during a regular clinic visit.
Following the patient’s initial appointment, the multidisciplinary team reviews all test results and a treatment plan is developed. Coordination also begins amongst the appropriately identified conjoined treatment clinics based on the patient’s diagnosis.
Clinical Research and Trials
Patients treated at the Center for Liver Diseases at Robert Wood Johnson University Hospital in partnership with Rutgers Robert Wood Johnson Medical School have access to physicians and researchers dedicated to clinical innovation, meaning patients may be eligible to enroll and participate in active research studies and clinical drug trials focused specifically on:
- Hepatitis B and C
- NAFLD/NASH
- Cirrhosis
- Alcoholic hepatitis
- Primary biliary cholangitis
- Primary sclerosis cholangitis
- Health care outcomes/cost-effective analyses in collaboration with the School of Public Health
Outreach and Education
A robust community outreach program offers the latest education and prevention information for the diverse patient populations affected by liver diseases and is the key to winning the fight against all liver diseases.
For more information, about the center for Liver Diseases and Liver Masses, please call 833-RWJ-LIVR (833-795-5487).